AMY ALBERTY: Open Payments
NPI 1598223851 · STILLWATER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,804 in 159 payments from 22 companies in 2025. Trend: 2023 $3,114 · 2024 $3,342 · 2025 $2,804
Food & beverage: $2,804
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 28 | $364 |
| ABBVIE INC. | 25 | $304 |
| SK Life Science, Inc. | 11 | $278 |
| Neurocrine BioSciences, Inc. | 15 | $247 |
| PFIZER INC. | 20 | $217 |
| ARGENX US, INC. | 9 | $198 |
| UCB, Inc. | 5 | $197 |
| ACADIA Pharmaceuticals Inc | 8 | $150 |
| Genentech USA, Inc. | 7 | $146 |
| Lundbeck LLC | 5 | $119 |
Products named: KESIMPTA, INGREZZA, NURTEC ODT, Rystiggo, VYVGART HYTRULO, UBRELVY, NUPLAZID, Ocrevus Zunovo.
Industry payments across OK — which companies pay providers there.
